Netherlands· NL-98fb2d527fd5
Delstrigo - Doravirine/Lamivudine/Tenofovir Disoproxil (as fumarate) MSD 100 mg/300 mg/245 mg, filmomhulde tabletten
A lamivudine, tenofovir disoproxil and doravirine product containing doravirine + lamivudine 0-water + tenofovirdisoproxilfumaraat, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Lamivudine, tenofovir disoproxil and doravirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR24 (lamivudine, tenofovir disoproxil and doravirine), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 8 of them publish a price we can compare per daily dose
Lamivudine, tenofovir disoproxil and doravirine · ATC J05AR24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DORAVIRINE + LAMIVUDINE 0-WATER + TENOFOVIRDISOPROXILFUMARAAT
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Netherlands (NL)
- ATC code
- J05AR24
- ATC class
- Lamivudine, tenofovir disoproxil and doravirine
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_idEU/1/18/1333
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J05AR24
Lamivudine, tenofovir disoproxil and doravirine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d56c3b48-b560-4f6e-90d6-210dfa3baa92 GET /v1/drugs/d56c3b48-b560-4f6e-90d6-210dfa3baa92?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/delstrigo-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Lamivudine, tenofovir disoproxil and doravirine",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp122170",
"excipients": [
"CARNAUBAWAS (E 903)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"GLYCEROLTRIACETAAT (E 1518)",
"HYPROMELLOSE (E 464)",
"HYPROMELLOSEACETAATSUCCINAAT",
"IJZEROXIDE GEEL (E 172)",
"LACTOSE 1-WATER",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMSTEARYLFUMARAAT",
"SILICIUMDIOXIDE (E 551)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"DORAVIRINE",
"LAMIVUDINE 0-WATER",
"TENOFOVIRDISOPROXILFUMARAAT"
],
"leaflet_url": null,
"authorised_at": "2018/11/22",
"procedure_number": "EMEA/H/C/004746",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/18/1333",
"additional_monitoring": "N"
}See everything about lamivudine, tenofovir disoproxil and doravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.